New developments in respiratory medicine: a primary immunodeficiency perspective.

Area of Science:

• Respiratory Medicine
• Immunology
• Pulmonology

Background:

• Adults with primary immunodeficiency disorders (PID) often experience significant respiratory complications.
• Understanding the evolving landscape of respiratory medicine is crucial for managing these patients.

Purpose of the Study:

• To review recent developments in respiratory medicine pertinent to clinicians managing adults with PID.
• To highlight advancements impacting the diagnosis and treatment of respiratory manifestations in PID.

Main Methods:

• Literature review focusing on impulse oscillometry, bronchoscopic techniques, MRI, PET imaging, and airway microbiome research.
• Analysis of novel therapeutic strategies for bronchiectasis and interstitial lung disease in the context of PID.

Main Results:

• Impulse oscillometry offers new insights into airway function.
• Advanced bronchoscopic techniques and imaging (MRI, PET) improve diagnostic capabilities.
• The human airway microbiome is increasingly recognized as a factor in respiratory health for PID patients.
• New treatments for bronchiectasis and interstitial lung disease show promise for PID management.

Conclusions:

• Progress in understanding lung health and disease, coupled with improved imaging and therapeutics, is driving new approaches.
• These advancements are essential for optimizing respiratory care and outcomes for individuals with PID.